Bayer AG is in discussions with governments in Europe, Japan and other wealthy countries to push for higher prices on new medicines as the US seeks to rein in drug costs. https://t.co/5UQa9uM3AK ...

Core Insights - Delays in pricing and reimbursement (P&R) processes are significant hurdles for the pharmaceutical industry, as highlighted by a survey from GlobalData's State of the Biopharmaceutical Industry report [1] Group 1: Impact of P&R Processes - Industry professionals rated the negative impact of P&R delays on business at 3.7 points on a scale of 1-5, indicating a substantial concern [2] - 22% of survey respondents identified P&R constraints as the most negative factor affecting their business in the next 12 months, second only to political and trade issues [3] Group 2: Pricing Pressures - Drug pricing has become a critical issue due to global inflation and geopolitical factors increasing development and commercialization costs [4] - The top three regulatory and macroeconomic trends negatively affecting the industry are all related to pharmaceutical pricing [5] - Key trends impacting drug pricing include inflation, the Inflation Reduction Act (IRA), the Most Favored Nation (MFN) policy, and International Referencing Pricing (IRP) [6] Group 3: Global Implications - Pricing pressures in the US may have global repercussions due to the use of IRP, which references lower drug prices from countries with lower GDP per capita [7] - This referencing can hinder the accessibility and affordability of medicines, potentially leading to delayed or canceled product launches [7]

The White House launched its drug-pricing website, dubbed TrumpRx, with obesity and infertility treatments among the first crop to appear with discounts on the government-run platform. https://t.co/a01BfjdH4o ...

🚨UPDATE: WHITE HOUSE LAUNCHES TRUMPRX DRUG PRICING PORTALAccording to the WSJ, TrumpRx drug-pricing portal, launched Thursday evening, offering cash-pay discounts on 43 brand-name drugs from five manufacturers: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.Drugs from 11 additional manufacturers will be added in coming months.BSCN (@BSCNews):🚨NEW: TRUMP ADMINISTRATION TO LAUNCH TRUMPRX DRUG PRICING PORTAL TONIGHT?TrumpRx is expected to launch Tonight, according @Axios.The direct-to-consumer pl ...

The White House on Thursday launched its drug-pricing website, dubbed TrumpRx, the culmination of efforts by the administration to bring down pharmaceutical costs for some consumers. ...

🚨NEW: TRUMP ADMINISTRATION TO LAUNCH TRUMPRX DRUG PRICING PORTAL TONIGHT?TrumpRx is expected to launch Tonight, according @Axios.The direct-to-consumer platform will connect cash-paying patients with manufacturer drug programs.Sixteen drugmakers have signed agreements, with advertised prices including GLP-1s Zepbound and Wegovy at $149/month, Repatha at $239/month, and Januvia at $100. ...

Core Viewpoint - Cigna Corp's Express Scripts has reached a settlement with the U.S. Federal Trade Commission regarding claims that its insulin pricing practices violated antitrust and consumer protection laws, and has agreed to implement changes aimed at lowering insulin costs for consumers [1] Group 1: Settlement Details - The settlement addresses allegations of antitrust violations related to insulin pricing practices [1] - Changes agreed upon by Express Scripts are intended to reduce insulin costs for consumers [1] Group 2: Regulatory Context - The U.S. Federal Trade Commission's involvement highlights ongoing scrutiny of pharmaceutical pricing practices [1] - This settlement may set a precedent for future regulatory actions against similar pricing practices in the healthcare industry [1]

Drugmakers are doing something unusual this year: slashing prices for several widely used medicines. 🔗 https://t.co/lRgRN5CAJx https://t.co/LOSg7h8fIY ...

At the start of every year, drugmakers raise prices for their medicines. But this year, they cut the prices of some popular treatments. https://t.co/6LkbVsqRHB ...

The US plans to slash the price it pays for Botox and diabetes drug Trulicity, the latest medicines to be targeted under legislation that’s expected to save the government more than $200 billion over a decade https://t.co/uRG8ldE5eG ...